Market News AIOpen the app

Alpha Tau Medical says all eight patients in its U.S. REGAIN trial for brain cancer are alive and responding well.

TrialRead the original at globenewswire.com
Good for DRTS

Alpha Tau Medical reported responses in all 6 assessed patients, including 5 complete responses, and all 8 treated patients remain alive. Only 6 patients were assessed, so these early results are encouraging but limited.

DRTS · Alpha Tau Medical

AI read · Good for DRTS

The AI's read

The findings support Alpha DaRT's promise and show it could be delivered without unexpected serious problems. The group was small, and follow-up is still limited, so lasting benefit remains unproven.

Get alerts for DRTS

Follow Alpha Tau Medical (DRTS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DRTS
Free on the App Store and Google Play, or on the web.